News

-

2012
- jan
- feb
- mar
- apr
- maj
- jun
- jul
- aug
- sep
- okt
- nov
- dec
2013
- jan
- feb
- mar
- apr
- maj
- jun
- jul
- aug
- sep
- okt
- nov
- dec

1/30/2012
Drugs with blockbuster potential from Umeå company Umecrine
Last year 6 million Euros were invested in the Umecrine group, by both Swedish and French investors. The company is developing drugs with fi...
Read more

Contact Press

Magdalena Krajewska
090-15 48 51,
070-294 49 19
magdalena.krajewska@biotechumea.se

Karin Borge Renberg
070-553 22 56
karin.borge-renberg@uminovainnovation.se

Manager

Kurt Strömgren
090-15 48 52,
070-688 47 55
kurt.stromgren@uminovainnovation.se